Zdrowie i gospodarka · 10/05/2022
FDA Clears Way for Glipizide Tablets Approval
The FDA has determined that Glucotrol tablets, 2.5mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.
Source: Federal Register — Food and Drug AdministrationOpen original release →